1. Home
  2. AMRX vs LBTYA Comparison

AMRX vs LBTYA Comparison

Compare AMRX & LBTYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

N/A

Current Price

$18.09

Market Cap

5.8B

Sector

Health Care

ML Signal

N/A

Logo Liberty Global Ltd.

LBTYA

Liberty Global Ltd.

N/A

Current Price

$9.83

Market Cap

4.0B

ML Signal

N/A

Company Overview

Basic Information
Metric
AMRX
LBTYA
Founded
2002
2004
Country
United States
Bermuda
Employees
N/A
6636
Industry
Biotechnology: Pharmaceutical Preparations
Cable & Other Pay Television Services
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
4.0B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
AMRX
LBTYA
Price
$18.09
$9.83
Analyst Decision
Strong Buy
Hold
Analyst Count
5
5
Target Price
$15.60
$13.72
AVG Volume (30 Days)
1.8M
2.1M
Earning Date
05-01-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
157.89
N/A
EPS
0.19
N/A
Revenue
N/A
N/A
Revenue This Year
$4.48
$15.41
Revenue Next Year
$7.13
$3.03
P/E Ratio
$94.32
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.67
$9.43
52 Week High
$18.39
$13.52

Technical Indicators

Market Signals
Indicator
AMRX
LBTYA
Relative Strength Index (RSI) 64.61 29.23
Support Level $12.46 N/A
Resistance Level $18.13 $11.56
Average True Range (ATR) 0.57 0.32
MACD -0.05 -0.06
Stochastic Oscillator 78.87 22.86

Price Performance

Historical Comparison
AMRX
LBTYA

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About LBTYA Liberty Global Ltd.

Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.

Share on Social Networks: